{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:54:41Z","timestamp":1790650481265,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ando.2007.04.003","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T03:01:51Z","timestamp":1329966111000},"page":"325-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cancer m\u00e9dullaire de\u00a0la\u00a0thyro\u00efde"],"prefix":"10.1016","volume":"68","author":[{"given":"P.","family":"Niccoli-Sire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Conte-Devolx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2007.04.003_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0046-8177(88)80262-4","article-title":"C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors","volume":"19","author":"Albores-Saavedra","year":"1988","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ando.2007.04.003_bib2","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Pronostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib3","first-page":"114","article-title":"Pentagastrin stimulation test and early diagnosis of medullary carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma","volume":"78","author":"Barbot","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib4","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Consensus: guidelines for diagnosis and therapy of multiple endocrine neoplasia type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib5","first-page":"7284","article-title":"ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.04.003_bib6","first-page":"1077","article-title":"The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes","volume":"62","author":"Carlomagno","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.04.003_bib7","first-page":"2234","article-title":"PP1 inhibitor induces degradation of RET MEN2A and RET MEN2B oncoproteins through proteosomal targeting","volume":"63","author":"Carniti","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.04.003_bib8","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1200\/JCO.2005.04.4917","article-title":"Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group","volume":"24","author":"Chatal","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","article-title":"Preoperative calcitonin levels are predictive of tumor size and cure in medullary thyroid carcinoma","volume":"85","author":"Cohen","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnci\/djh184","article-title":"Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A associated medullary thyroid carcinoma","volume":"96","author":"Cucurru","year":"2004","journal-title":"J. Nath. Cancer Inst."},{"key":"10.1016\/j.ando.2007.04.003_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-8981(01)00582-4","article-title":"Clinical evaluation of a new sensitive calcitonin assay: study of specificity","volume":"311","author":"D\u2019Herbomez","year":"2001","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.ando.2007.04.003_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1210\/jc.2003-030550","article-title":"Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10864 patients with nodular thyroid disorders","volume":"89","author":"Elisei","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib13","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1210\/jc.2005-2401","article-title":"Chemoembolisation for liver metastases from medullary thyroid carcinoma","volume":"91","author":"Fromigue","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/bjs.4875","article-title":"Increased calcitonin level in thyroid nodules without medullary carcinoma","volume":"92","author":"Gibelin","year":"2005","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ando.2007.04.003_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00006231-200405000-00003","article-title":"18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature","volume":"25","author":"Gotthardt","year":"2004","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.ando.2007.04.003_bib16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0046-8177(94)90124-4","article-title":"C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a quantitative autopsy study of 112 cases","volume":"25","author":"Guyetant","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ando.2007.04.003_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/10507250150500694","article-title":"Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases","volume":"11","author":"Hahms","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2007.04.003_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejso.2005.03.007","article-title":"Central neck dissection in the management of sporadic medullary microcarcinoma","volume":"31","author":"Hamy","year":"2005","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/ejso.2000.0981","article-title":"Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival","volume":"26","author":"Hyer","year":"2000","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-002-6613-0","article-title":"Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels","volume":"26","author":"Iacobone","year":"2002","journal-title":"World J. Surg."},{"key":"10.1016\/j.ando.2007.04.003_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jc.2003-030709","article-title":"Frequency and relevance of elevated calcitonin levels in patients with neoplasic and non-neoplasic thyroid disease and in healthy subjects","volume":"89","author":"Karanikas","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2004-815727","article-title":"Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: german evidenced-based consensus recommendations","volume":"112","author":"Karges","year":"2004","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.ando.2007.04.003_bib23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00000478-199806000-00009","article-title":"C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin","volume":"22","author":"Kaserer","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ando.2007.04.003_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, pronostic factors, and comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2007.04.003_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/thy.1998.8.265","article-title":"Pentagastrin testing in patients with renal insuficiency: normal responsivity of mature calcitonin","volume":"8","author":"Lissak","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2007.04.003_bib26","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1909::AID-CNCR21>3.0.CO;2-A","article-title":"Improved prediction of calcitonin normalisation in medullary thyroid carcinoma patients by quantitative lymph node analysis","volume":"88","author":"Machens","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ando.2007.04.003_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","article-title":"Pattern of nodal metastasis for primary and reoperative thyroid cancer","volume":"28","author":"Machens","year":"2002","journal-title":"World J. Surg."},{"key":"10.1016\/j.ando.2007.04.003_bib28","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/jc.2004-1836","article-title":"Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level","volume":"90","author":"Machens","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib29","first-page":"212","article-title":"Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin","volume":"53","author":"Medina-Franco","year":"2001","journal-title":"Rev. Invest. Clin."},{"key":"10.1016\/j.ando.2007.04.003_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ejso.2004.05.016","article-title":"Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin","volume":"30","author":"Miraill\u00e9","year":"2004","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2265.1992.tb00955.x","article-title":"Results of long-term continuous subcutaneous octreotide administration of 14 patients with medullary thyroid carcinoma","volume":"36","author":"Modigliani","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.04.003_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors of survival and biological cure in medullary thyroid carcinoma: results in 899 patients","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.04.003_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","article-title":"Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extend of node dissection","volume":"229","author":"Moley","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ando.2007.04.003_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-8981(88)90365-8","article-title":"Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies","volume":"174","author":"Motte","year":"1988","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.ando.2007.04.003_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/eje.0.1320075","article-title":"Abnormal basal calcitonin level and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis","volume":"132","author":"Niccoli","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ando.2007.04.003_bib36","first-page":"15","article-title":"Les hypercalcitonin\u00e9mies en dehors des cancers m\u00e9dullaires de la thyro\u00efde","volume":"57","author":"Niccoli","year":"1996","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.ando.2007.04.003_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem.82.2.3737","article-title":"Interest of routine measurement of serum calcitonin (CT): study in a large series of thyroidectomized patients","volume":"82","author":"Niccoli","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.immbio.2003.09.001","article-title":"N\u00e9oplasie endocrinienne multiple de type 2: places respectives de la biologie et de la g\u00e9n\u00e9tique mol\u00e9culaire","volume":"18","author":"Niccoli-Sire","year":"2003","journal-title":"Immunoanalyse Biol. Sp\u00e9cialis\u00e9e"},{"key":"10.1016\/j.ando.2007.04.003_bib39","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1210\/jcem.86.8.7767","article-title":"Familial medullary thyroid carcinoma (FMTC) with non-cysteine RET mutations: phenotype-genotype relationship in a large series of patients","volume":"86","author":"Niccoli-Sire","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1054\/bjoc.2000.1314","article-title":"Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozotocin and 5 FU-dacarbazine","volume":"83","author":"Nocera","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ando.2007.04.003_bib41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/oxfordjournals.annonc.a058984","article-title":"Chemotherapy with dacarbazine and 5-Fluorouracil in advanced medullary thyroid cancer","volume":"5","author":"Orlandi","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/thy.1999.9.579","article-title":"Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter","volume":"9","author":"Ozgen","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2007.04.003_bib43","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.bjc.6600930","article-title":"Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging","volume":"88","author":"Pellegritti","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ando.2007.04.003_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jso.20184","article-title":"Medullary thyroid carcinoma including MEN 2A and MEN 2B syndromes","volume":"89","author":"Quayle","year":"2005","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ando.2007.04.003_bib45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2265.1995.tb02662.x","article-title":"Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules","volume":"42","author":"Rieu","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ando.2007.04.003_bib46","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1210\/jc.2002-021713","article-title":"Rationale for central and bilateral lymh node dissection in sporadic and hereditary medullary thyroid cancer","volume":"88","author":"Scollo","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib47","first-page":"51","article-title":"Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma","volume":"94","author":"Stein","year":"2002","journal-title":"Effectiveness of Dacarbazine. Cancer"},{"key":"10.1016\/j.ando.2007.04.003_bib48","first-page":"559","article-title":"CEP-701 and CEP-751 inhibits constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth","volume":"63","author":"Strock","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.04.003_bib49","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0003-3944(01)00609-5","article-title":"R\u00e9intervention pour carcinome m\u00e9dullaire de la thyro\u00efde: r\u00e9sultats \u00e0 long terme","volume":"126","author":"Tamagnini","year":"2001","journal-title":"Ann. Chir."},{"key":"10.1016\/j.ando.2007.04.003_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/bjs.4860","article-title":"Lymph node involvement in macroscopic medullary thyroid carcinoma","volume":"92","author":"Tamagnini","year":"2005","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ando.2007.04.003_bib51","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1158\/0008-5472.CAN-04-4561","article-title":"ZD6474, suppresses oncogenic RET isoforms in a drosophila model for type 2 MEN syndromes and papillary thyroid carcinoma","volume":"65","author":"Vidal","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ando.2007.04.003_bib52","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/jcem.82.5.3949","article-title":"Routine measurement of plasma calcitonin in nodular thyroid disease","volume":"82","author":"Vierhapper","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ando.2007.04.003_bib53","first-page":"302","article-title":"Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families","volume":"58","author":"Wion-Barbot","year":"1997","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.ando.2007.04.003_bib54","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0039-6060(03)00408-2","article-title":"Medullary thyroid carcinoma: results of a standardized surgical approach in a contempory series of 80 consecutive patients","volume":"134","author":"Yen","year":"2003","journal-title":"Surgery"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426607000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:25Z","timestamp":1757716945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426607000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0003426607000844"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2007.04.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer m\u00e9dullaire de\u00a0la\u00a0thyro\u00efde","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2007.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}